GlassScriptPhysician profile
Erin Salinas
NPI 1245551845
$3,295.65
in general payments reported to CMS, 2019-2025
13 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2021: $23.31 · 2022: $614 · 2023: $514 · 2024: $434 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.12 |
| Education | $169.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,237.21 | 2019-2023 | Da Vinci Surgical System |
| Seagen INC. | $577.50 | 2021-2023 | Tivdak |
| Pfizer INC. | $402.26 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $276.30 | 2023-2024 | Lynparza |
| Glaxosmithkline, LLC. | $239.80 | 2022-2024 | Zejula |
| Myriad Genetic Laboratories, INC. | $129.07 | 2022 | |
| Immunogen, INC. | $106.85 | 2023 | Elahere |
| Foundation Medicine, INC. | $104.02 | 2019 | |
| Tesaro, INC. | $88.50 | 2019 | |
| Medical Device Business Services, INC. | $86.95 | 2019 | |
| Baxter Healthcare | $19.84 | 2023 | Tisseel |
| Gilead Sciences, INC. | $16.55 | 2025 | Trodelvy |
| Clovis Oncology, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Salinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.